Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacovigilance study of the association between dipeptidyl peptidase–4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS)
Katsuhiro Ohyama, Junichiro Shindo, Tomohiro Takahashi, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Time-to-onset Analysis of Rhabdomyolysis due to Different Proton Pump Inhibitors Using a Pharmacovigilance Database
Katsuhiro Ohyama, Megumi Iida, SHOTA AKIYAMA, et al.
In Vivo (2024) Vol. 38, Iss. 3, pp. 1285-1291
Open Access | Times Cited: 4
Interaction between dipeptidyl-peptidase-4 inhibitors and drugs acting on renin angiotensin aldosterone system for the risk of angioedema: a pharmacovigilance assessment using disproportionality and interaction analyses
Kannan Sridharan, Gowri Sivaramakrishnan
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Adaptation and Linguistic Validation of Angioedema PROMs in Latvian for Assessing Recurrent Angioedema
Lāsma Lapiņa, Adīne Kaņepa, Maksims Zolovs, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1375-1375
Open Access
Concomitant medication in patients with bradykinin‐mediated angioedema – there's more than ACE inhibitors
Robin Lochbaum, Thomas K. Hoffmann, Jens Greve, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 11, pp. 1283-1289
Open Access | Times Cited: 9
Comprehensive safety profile of dipeptidyl peptidase-4 inhibitors: a post-marketing study based on FAERS database using signal detection algorithms
Beema T Yoosuf, Muhammed Favas, Pinaki Dutta, et al.
Expert Opinion on Drug Safety (2024), pp. 1-13
Closed Access | Times Cited: 2
Discovery of Nine Dipeptidyl Peptidase-4 Inhibitors from Coptis chinensis Using Virtual Screening, Bioactivity Evaluation, and Binding Studies
Zixi Zhao, Ruonan Ma, Yuqing Ma, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2304-2304
Open Access | Times Cited: 2
Factors contributing to the adverse drug reactions associated with the dipeptidyl peptidase-4 (DPP-4) inhibitors: A scoping review
Swetha R. Reghunath, Muhammed Rashid, Viji Pulikkel Chandran, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 7, pp. 102790-102790
Closed Access | Times Cited: 4
Association of Torsade de Pointes and QT Prolongation With Antifungal Triazoles: Analysis Using a Pharmacovigilance Database
Katsuhiro Ohyama, SHOTA AKIYAMA, Megumi Iida, et al.
In Vivo (2023) Vol. 37, Iss. 6, pp. 2719-2725
Open Access | Times Cited: 4
Medikamente als Auslöser Bradykinin‐vermittelter Angioödeme – mehr als ACE‐Hemmer
Robin Lochbaum, Thomas K. Hoffmann, Jens Greve, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 11, pp. 1283-1290
Open Access | Times Cited: 2
Adverse Skin and Systemic Reactions to Antidiabetic Treatments
Florence Tétart, Krisztián Gáspár
Springer eBooks (2024), pp. 337-350
Closed Access
Angiotensin-Converting Enzyme Inhibitors and Other Medications Associated With Angioedema
Layne Landry, Taylor Witten, Ahmed I Anwar, et al.
Cureus (2023)
Open Access
Some DPP-4 inhibitors may increase risk of angioedema

Reactions Weekly (2022) Vol. 1919, Iss. 1, pp. 12-12
Closed Access
Page 1

Scroll to top